HPLC goes green
As an analytical technique, HPLC provides fast separation and quantification of compounds in complex matrices with high efficiency, resolution and sensitivity; but the use of acetonitrile and methanol as solvents give it a number of drawbacks, environmentally. A water-enriched mobile phase has been proposed, which could provide a new environmentally friendly methodology.
As an analytical technique, HPLC provides fast separation and quantification of compounds in complex matrices with high efficiency, resolution and sensitivity; but the use of acetonitrile and methanol as solvents give it a number of drawbacks, environmentally. A water-enriched mobile phase has been proposed, which could provide a new environmentally friendly methodology.
Acetonitrile and methanol are common in mobile phases, but their toxicity means the mixtures have to be treated as chemical waste. Cyclodextrins are semi-natural compounds produced from starch; they are non-toxic, can be chemically modified to suit a number of techniques, and can allow the reduction of the solvent/water ratio. A study published in Green Chemistry1 has investigated their use as a mobile phase additive for greener HPLC separations.
According to the study, the use of cyclodextrins as mobile phase additives allowed the researchers to increase the proportion of water in the mobile phases without a loss in resolution or efficiency, reducing the proportion of organic solvent content in the mobile phase from 70% to 50%, and allowing the more toxic acetonitrile to be replaced with methanol and ethanol as the organic component.
The study concluded that the presence of cyclodextrins in the mobile phases offers the potential for traditional HPLC to become “an attractive eco-separation technique using conventional and inexpensive columns and stationary phases, under simple and user-friendly experimental conditions."
1. V. González-Ruiz et al., Green Chem., 13, 115–126 (2011).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
